Delivery Order SPE2DB20D2014-SPE2DB25FD01M
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 90 units. This contract is a firm fixed-price delivery order with a ceiling value of $4,167.80 and an ultimate completion date of September 2, 2025. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.41 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (90-count units) with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Pioglitazone HCL 45 mg tablets in quantities of 500 units, with a ceiling value of $1,010.78. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count) at a firm fixed price of $3,758.40, with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,749.28 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, with an ultimate completion date of July 23, 2025. This competitive, non-set-aside contract was awarded on July 22, 2025, with firm fixed pricing and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,498.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $177,000 firm fixed price delivery order to supply 30-count bottles of 15mg pioglitazone HCl tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution center. The order period of performance is September 21-22, 2023. As a major supplier of pharmaceuticals to the Department of Defense through contracts like the DLA's Pharmaceutical Prime Vendor program, Amerisourcebergen will deliver...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pioglitazone-Metformin 15-850mg in 60-count quantities, with a contract ceiling value of $2,068.17. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.86 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 45 mg tablets (90-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD01MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $3,170.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. As a child contract action, this delivery order is executed under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply agreement running through December 2026 that enables the company to supply medications and medical commodities to military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare programs. The company's federal contract portfolio demonstrates extensive experience delivering a diverse range of pharmaceutical products across multiple therapeutic domains through competitively awarded, firm fixed-price arrangements with the DLA. This specific delivery order for Pioglitazone—a diabetes management medication—reflects the company's ongoing role as a primary supplier of both brand-name and generic pharmaceuticals supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/16/25 |